You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 1, January 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Pediatric Ophthalmology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Treatment of Convergence Insufficiency

Arch Ophthalmol. 2005;123:100-101.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Scheiman et al1 are to be congratulated for using good science and methodology to study the treatment of convergence insufficiency (CI). Although CI is quite common, with reported rates of prevalence ranging between 2.25% and 8.3%,1 there is a paucity of good studies that compare popular treatment modalities. As such, the pilot study by Scheiman and colleagues does move forward our understanding of the treatment of this disorder. They compared a rather intensive (and relatively expensive) office-based treatment program with both a very minimally intensive program of home exercises and a placebo treatment. Although the number of subjects was small in this pilot study (between 11 and 15 in each of the 3 treatment arms), the authors found that their intensive office-based program worked quite well. Both the home-based treatment and the placebo, however, did not.

Like all scientific studies, this one can only answer the specific questions it asks. . . . [Full Text of this Article]


AUTHOR INFORMATION
Burton J. Kushner, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Learning Disabilities, Dyslexia, and Vision
American Academy of Pediatrics, Section on Ophthal et al.
Pediatrics 2009;124:837-844.
ABSTRACT | FULL TEXT  

Randomized Clinical Trial of Treatments for Symptomatic Convergence Insufficiency in Children
Convergence Insufficiency Treatment Trial Study Gr
Arch Ophthalmol 2008;126:1336-1349.
ABSTRACT | FULL TEXT  

Treatment Options for Symptomatic Convergence Insufficiency
Wallace
Arch Ophthalmol 2008;126:1455-1456.
FULL TEXT  

Pediatric Strabismus
Donahue
NEJM 2007;356:1040-1047.
FULL TEXT  

Convergence Insufficiency: Randomized Clinical Trial--Reply
Scheiman et al.
Arch Ophthalmol 2005;123:1760-1761.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.